Copyright
©The Author(s) 2020.
World J Stem Cells. Jul 26, 2020; 12(7): 676-687
Published online Jul 26, 2020. doi: 10.4252/wjsc.v12.i7.676
Published online Jul 26, 2020. doi: 10.4252/wjsc.v12.i7.676
Year | First author | Study type | Patientnumber,test/control | Edemalocation | Cell type | Cell number | Injection method,location/depth | Follow-up inmoassessment | Results |
2016 | Toyserkani et al[30] | Pilot study | 1/0 | Upper limb | Freshly isolated autologous ADSCs plus fat graft | 4.07 × 107 plus 10 mL lipoaspirate | Axillary region (8 points) | 4 mo In vitro cell characterization (cell count, viability, and surface marker) | Great reduction in symptoms of arm heaviness and tension, reduction in need for compression therapy |
Circumference measurements | Volume reduction in affected arm | ||||||||
Dual-energy X-ray absorptiometry scans Adverse events | No postoperative complications or adverse events | ||||||||
2017 | Toyserkani et al[31] | Pilot study | 10/0 | Upper limb | Freshly isolated autologous ADSCs plus fat graft | 5 × 107 plus 30 mL lipoaspirate | Axilla (8 points) | 6 mo In vitro cell characterization (cell count, viability, and surface marker) | A small volume reduction but not significant |
Circumference measurements | Patient-reported outcomes improved significantly over time | ||||||||
Dual-energy X-ray absorptiometry scans | Half of the patients reduced their use of conservative management | ||||||||
Patient-reported outcome and safety questionnaire assessment | No noteworthy serious adverse events | ||||||||
2019 | Toyserkani et al[32] | Pilot study | 10/0 | Upper limb | Freshly isolated autologous ADSCs plus fat graft | 5 × 107 plus 30 mL lipoaspirate | Axilla (8 points) | 12 mo In vitro cell characterization (cell count, viability, and surface marker) | No significant change in volume |
Circumference measurements | Patient-reported outcomes improved significantly over time | ||||||||
Dual-energy X-ray absorptiometry scans | Five patients reduced their use of conservative management | ||||||||
Patient-reported outcome and safety questionnaire assessment | Quantitative lymphoscintigraphy showed no improvement on the lymphedema-affected arms | ||||||||
Lymphoscintigraphy changes | ADRCs were well-tolerated and only minor transient adverse events related to liposuction were noted |
- Citation: Li ZJ, Yang E, Li YZ, Liang ZY, Huang JZ, Yu NZ, Long X. Application and prospect of adipose stem cell transplantation in treating lymphedema. World J Stem Cells 2020; 12(7): 676-687
- URL: https://www.wjgnet.com/1948-0210/full/v12/i7/676.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v12.i7.676